Rapid localized spread and immunologic containment define Herpes simplex virus-2 reactivation in the human genital tract
about
Viral kinetic modeling: state of the artThe challenges and opportunities for the development of a T-cell epitope-based herpes simplex vaccineMathematical modeling of herpes simplex virus-2 suppression with pritelivir predicts trial outcomes.Mathematical Modeling Predicts that Increased HSV-2 Shedding in HIV-1 Infected Persons Is Due to Poor Immunologic Control in Ganglia and Genital MucosaHerpes simplex virus-2 transmission probability estimates based on quantity of viral sheddingProspects and perspectives for development of a vaccine against herpes simplex virus infections.Herpes simplex virus-2 genital tract shedding is not predictable over months or years in infected persons.Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humansAntiviral activity of a single-domain antibody immunotoxin binding to glycoprotein D of herpes simplex virus 2.Topical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB/gD ectodomains induces genital-tissue-resident memory CD8+ T cells and reduces genital disease and viral shedding after HSV-2 challengePlasma and cerebrospinal fluid herpes simplex virus levels at diagnosis and outcome of neonatal infection.Oral and Vaginal Tenofovir for Genital Herpes Simplex Virus Type 2 Shedding in Immunocompetent Women: A Double-Blind, Randomized, Cross-over Trial.Current Concepts for Genital Herpes Simplex Virus Infection: Diagnostics and Pathogenesis of Genital Tract SheddingMucosal HSV-2 Specific CD8+ T-Cells Represent Containment of Prior Viral Shedding Rather than a Correlate of Future Protection.Generating protective immunity against genital herpesRapid viral expansion and short drug half-life explain the incomplete effectiveness of current herpes simplex virus 2-directed antiviral agents.Improving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D.Transient Oral Human Cytomegalovirus Infections Indicate Inefficient Viral Spread from Very Few Initially Infected Cells.Keratinocytes produce IL-17c to protect peripheral nervous systems during human HSV-2 reactivation.HSV2 reactivation and myelitis following influenza vaccination.Image analysis for accurately counting CD4+ and CD8+ T cells in human tissue.T cell memory. Skin-resident memory CD8⁺ T cells trigger a state of tissue-wide pathogen alert.Kinetics of Double Stranded DNA Viremia after Allogeneic Hematopoietic Cell Transplantation.Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.Virus and host-specific differences in oral human herpesvirus shedding kinetics among Ugandan women and children.Model-based estimation of superinfection prevalence from limited datasets.Effects of spatiotemporal HSV-2 lesion dynamics and antiviral treatment on the risk of HIV-1 acquisition.A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infectionA Fixed Spatial Structure of CD8 T Cells in Tissue during Chronic HSV-2 Infection
P2860
Q26824655-3E9776B8-A421-4BB4-BB15-E5D72ADF5100Q27021292-4DA4B4C4-EB39-4252-B871-435D7091EA9AQ27324453-65BD75B2-6342-4270-8803-ECC968F752B5Q27347896-21C93E2A-2305-49A5-A004-318D5970817EQ28236882-BAA46B89-0A57-4114-87E9-F38374818170Q34431547-68F54D1E-EAA7-4CE1-8519-DCE3BA48CCE8Q34464387-8DAA8C8C-CC52-4414-A447-61B7FACE9FBAQ34593833-AA4F694F-6E02-4CBD-96B7-E50E2C5C5F91Q34923432-CCD3899D-45C8-45AF-909A-126A169E3391Q34992660-2764651C-14F2-4EA3-9946-08C37205A436Q35236237-26959047-50CE-469B-ABF3-A6557EDB437CQ36306926-9C010341-B19F-4EAF-8D80-590A7CE257F4Q36630996-C84311E6-F2AF-4E14-A3BD-AD995A0E4D79Q37051012-F5499577-36DF-40E7-AB15-9407DC590C98Q37283993-985A5C82-8342-4690-9584-5E94743C8ED9Q37335794-7C0C0742-B23F-496F-8B66-62D8E8C28909Q38241377-5C5CB981-4C07-404D-976C-79588F7B4BF0Q38850665-C3A81695-A1DB-4FB5-A261-BC0E708ABBCFQ40140509-188D1C7E-36C2-40EE-9A06-BAE020AA0D08Q40565933-9A35F628-AF27-4206-8CB8-645139E4B8BEQ41161711-603CF94F-EF9D-4BD1-956C-34F8D58EC060Q41717756-D6743090-434A-41A0-8625-EB290A807C71Q41919003-F51E62DA-4193-4103-A88D-5C51C759F4A8Q41928445-CA7A5EC3-2B97-4251-AAB4-8C7F7BD53496Q42376111-BD555008-669F-40D8-A839-D2BB02B3DB13Q50533686-6B1561D4-E572-462F-ACD2-75CBB04C6439Q52561266-7DE2800B-36A4-48C3-B2F0-334264AF8EB6Q57072187-E6A2F4D7-87CB-4C33-9C39-D98B5E567F20Q57269664-77C608EA-7E7C-400C-B8AE-86DB71309885
P2860
Rapid localized spread and immunologic containment define Herpes simplex virus-2 reactivation in the human genital tract
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Rapid localized spread and imm ...... ion in the human genital tract
@ast
Rapid localized spread and imm ...... ion in the human genital tract
@en
type
label
Rapid localized spread and imm ...... ion in the human genital tract
@ast
Rapid localized spread and imm ...... ion in the human genital tract
@en
prefLabel
Rapid localized spread and imm ...... ion in the human genital tract
@ast
Rapid localized spread and imm ...... ion in the human genital tract
@en
P2093
P2860
P50
P356
P1433
P1476
Rapid localized spread and imm ...... ion in the human genital tract
@en
P2093
Amalia Magaret
Barry Robinson
Christine Johnston
David Swan
Joshua T Schiffer
Karen E Mark
Keith R Jerome
Negusse Ocbamichael
Ramzi Al Sallaq
P2860
P304
P356
10.7554/ELIFE.00288
P407
P577
2013-04-16T00:00:00Z